Skip to search formSkip to main contentSkip to account menu

LY 544344

Known as: LY-544344, LY544344 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
The intestinal absorption of a prodrug of the mGlu2/3 receptor agonist LY354740 is mediated by PEPT1: in situ rat intestinal perfusion studies.
LY354740 is a potent mGlu2/3 agonist with a limited oral bioavailability. Its alanyl prodrug, LY544344, showed high affinity to… 
Highly Cited
2005
Highly Cited
2005
Effects of a metabotropic glutamate2/3 receptor agonist (LY544344/LY354740) on panic anxiety induced by cholecystokinin tetrapeptide in healthy humans: preliminary results
RationalePreclinical findings have repeatedly shown an anxiolytic-like action of agonists at metabotropic glutamate receptors… 
Review
2005
Review
2005
LY-544344. Eli Lilly.
  • W. Danysz
  • IDrugs : the investigational drugs journal
  • 2005
  • Corpus ID: 21820180
Eli Lilly and Co is developing LY-544344, a prodrug of the metabotropic glutamate receptor 2/3 agonist LY-354740, for the… 
2005
2005
Improved Bioavailability of the mGlu 2 / 3 Receptor Agonist LY 354740 Using a Prodrug Strategy : In Vivo Pharmacology of LY 544344
Numerous studies have indicated that selective agonists of group II metabotropic glutamate (mGlu) receptors, such as LY354740 and… 
2004
2004
Pharmacodynamics of a novel anxiolytic (LY544344)
2004
2004
Gateways to clinical trials.
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)